Standout Papers

GLP-1 Receptor Agonist... 2017 2026 2020 2023 522
  1. GLP-1 Receptor Agonists and Risk for Cirrhosis and Related Complications in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (2024)
    Fasiha Kanwal, Jennifer R. Kramer et al. JAMA Internal Medicine
  2. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease (2017)
    Brandon J. Perumpail, Muhammad Ali Khan et al. World Journal of Gastroenterology

Immediate Impact

3 from Science/Nature 87 standout
Sub-graph 1 of 18

Citing Papers

Type 2 Diabetes Mellitus: New Pathogenetic Mechanisms, Treatment and the Most Important Complications
2025 Standout
Phase 3 Trial of Semaglutide in Metabolic Dysfunction–Associated Steatohepatitis
2025 Standout
1 intermediate paper

Works of George Cholankeril being referenced

Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular Mortality
2020
Low-Normal Thyroid Function Is Associated With Advanced Fibrosis Among Adults in the United States
2018
and 1 more

Author Peers

Author Last Decade Papers Cites
George Cholankeril 2835 1731 825 143 3.8k
Sanjaya K. Satapathy 2432 1669 656 169 3.6k
Mark Muthiah 2245 1124 982 174 3.6k
Tracey G. Simon 3395 1937 1100 108 4.6k
Wah‐Kheong Chan 2630 1377 1013 109 3.5k
Norberto C. Chávez‐Tapia 2671 1554 869 178 4.4k
Nimer Assy 1914 1040 991 91 3.0k
Juan Pablo Arab 3529 1647 973 178 5.1k
Marcello Persico 4154 3172 954 197 6.3k
Satheesh Nair 2496 2142 681 108 4.2k
Christian Datz 2965 1931 787 171 6.1k

All Works

Loading papers...

Rankless by CCL
2026